VHT — Volpara Health Technologies Share Price
0.000.00%
Last trade - 00:00- AU$289.99m
- AU$279.10m
- NZ$35.01m
- 74
- 14
- 96
- 65
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 6.6 | ||
| Price to Tang. Book | 212.61 | ||
| Price to Free Cashflow | 233.51 | ||
| Price to Sales | 8.32 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -22.4% | ||
| Return on Equity | -17.33% | ||
| Operating Margin | -28.7% | ||
Financial Summary
| Year End 31st Mar | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | NZ$m | 5 | 12.6 | 19.75 | 26.11 | 35.01 | 38.7 | 46.38 | 65.59% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Volpara Health Technologies Limited is a New Zealand-based company, which makes software for healthcare providers to understand cancer risk, enabling patients to make personal care decisions and guide recommendations about additional imaging, genetic testing and other interventions. Its artificial intelligence (AI)-powered image analysis enables radiologists to quantify breast tissue with precision and helps technologists produce mammograms with optimal image quality, positioning, compression and dose. Its software streamlines operations and provides performance insights that support continuous quality improvement. Its software is used in over 2,000 facilities by more than 5,600 technologists, impacting nearly 15 million patients globally. It helps providers conduct more than three million cancer risk assessments each year and can be deployed stand-alone or fully integrated with electronic health record systems, mammography reporting systems, imaging hardware and genetic laboratories.
Directors
- Paul Reid CHM
- Ralph Highnam CEO
- Craig Hadfield CFO
- David Murray CTO
- Julian Marshall CMO
- David Lee VPR
- Anton Zerle VPR
- David Mezzoprete VPR
- Penelope Gibson OTH
- Ian Hendra OTH
- Mark Koeniguer OTH
- John Diddams SEC
- Roger Allen NED
- Karin Lindgren NID
- John Pavlidis NID
- Last Annual
- March 31st, 2023
- Last Interim
- September 30th, 2023
- Incorporated
- February 24th, 2009
- Public Since
- April 27th, 2016
- No. of Shareholders
- 15,193
- No. of Employees
- 156
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- Australian Stock Exchange - SEATS
- Shares in Issue
- 254,374,000
- Address
- Level 12, 86 Victoria Street, WELLINGTON, 6011
- Web
- https://www.volparahealth.com/
- Phone
- +64 44996029
- Auditors
- PricewaterhouseCoopers
Upcoming Events for VHT
Q1 2025 Volpara Health Technologies Ltd Earnings Release
Volpara Health Technologies Ltd Annual Shareholders Meeting
Similar to VHT
4DMedical
Australian Stock Exchange - SEATS
Adherium
Australian Stock Exchange - SEATS
Allegra Medical Technologies
Australian Stock Exchange - SEATS
Ansell
Australian Stock Exchange - SEATS
Anteris Technologies
Australian Stock Exchange - SEATS
FAQ
What is the Volpara Health Technologies share price?
As of Today at 19:23 UTC, shares in Volpara Health Technologies are trading at AU$1.14. This share price information is delayed by 15 minutes.
How has the Volpara Health Technologies share price performed this year?
Shares in Volpara Health Technologies last closed at AU$1.14 and the price had moved by +50.99% over the past 365 days. In terms of relative price strength the Volpara Health Technologies share price has outperformed the ASX All Ordinaries Index by +40.64% over the past year.
What are the analyst and broker recommendations for Volpara Health Technologies?
The overall consensus recommendation for Volpara Health Technologies is Hold. You can view the full broker recommendation list by unlocking its StockReport.
What is the Volpara Health Technologies dividend yield?
Volpara Health Technologies does not currently pay a dividend.
Does Volpara Health Technologies pay a dividend?
Volpara Health Technologies does not currently pay a dividend.
When does Volpara Health Technologies next pay dividends?
Volpara Health Technologies does not currently pay a dividend.
How do I buy Volpara Health Technologies shares?
To buy shares in Volpara Health Technologies you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Volpara Health Technologies?
As of the previous close price of AU$1.14, shares in Volpara Health Technologies had a market capitalisation of AU$289.99m.
Where are Volpara Health Technologies shares listed?
Here are the trading details for Volpara Health Technologies:
- Country of listing: Australia
- Exchange: ASX
- Ticker Symbol: VHT
What kind of share is Volpara Health Technologies?
Based on an overall assessment of its quality, value and momentum Volpara Health Technologies is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Volpara Health Technologies share price forecast for 2024?
The analyst consensus target price for shares in Volpara Health Technologies is AU$0.97. That is 15.08% below the last closing price of AU$1.14.
Analysts covering Volpara Health Technologies currently have a consensus Earnings Per Share (EPS) forecast of -NZ$0.03 for the next financial year.
What is the trend in the Volpara Health Technologies share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Volpara Health Technologies. Over the past six months, its share price has outperformed the ASX All Ordinaries Index by +52.04%.
As of the last closing price of AU$1.14, shares in Volpara Health Technologies were trading +25.44% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Volpara Health Technologies PE Ratio?
The Volpara Health Technologies PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at AU$1.14.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Volpara Health Technologies?
Volpara Health Technologies' management team is headed by:
- Paul Reid - CHM
- Ralph Highnam - CEO
- Craig Hadfield - CFO
- David Murray - CTO
- Julian Marshall - CMO
- David Lee - VPR
- Anton Zerle - VPR
- David Mezzoprete - VPR
- Penelope Gibson - OTH
- Ian Hendra - OTH
- Mark Koeniguer - OTH
- John Diddams - SEC
- Roger Allen - NED
- Karin Lindgren - NID
- John Pavlidis - NID